Inibio
Gyeongju
About Inibio
Inibio is a biomedical firm that specializes in medical aesthetics and develops botox from organic components.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $45.9M
- Funding stage: Early Stage Venture
- Last round: Series B (Feb 2022)
- Website: inibio.com
- Phone: +82 032 683 8080
Industries & Categories
Biopharma, Pharmaceutical
Canonical: https://fsome.com/organization/inibio-166246 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.